While joining Gilead Sciences in welcoming the FDA's approval of a twice-yearly shot to prevent HIV, public health advocates ...

Presented by Alliance for Aging Research {beacon} Health Care Health Care   PRESENTED BY  The Big Story  Trump administration ...

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.

The FDA has approved Yeztugo, the world’s first twice-a-year HIV prevention shot, proven to stop 99.9% of infections in ...

WASHINGTON — (AP) — The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...

It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?